AGR2 is able to upregulate the EGFR ligand amphiregulin (114) and the expression of cyclin D1 (115), being consistent with the finding that, in primary BC, the level of cyclin D1 correlates with that of AGR2 (116). Here, AGR2 is linked to breast cancer.